Structure of Toxic Shock Syndrome Toxin-1

  • Douglas H. Ohlendorf
  • David T. Mitchell
  • G. Sridhar Prasad
  • R. Radhakrishnan
  • Cathleen A. Earhart
  • Patrick M. Schlievert
Part of the Molecular Biology Intelligence Unit book series (MBIU)

Abstract

Toxic shock syndrome toxin-1 (TSST-1) is a member of a group of toxins known as pyrogenic toxin superantigens (PTSAgs). These toxins are produced by Staphylococcus aureus and a number of Group A streptococci. Included in the family of PTSAgs are staphylococcal enterotoxins A through H excluding F (SEA, SEB, SEC1, SEC2, SEC3, SED, SEE, SEG and SEH), exotoxins A through C from Streptococcus pyogenes (SPEA, SPEB and SPEC), and TSST-1 from S. aureus.

Keywords

Zinc Toxicity Cysteine Proline Bacillus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tranter HS. Foodborne staphylococcal illness. Lancet 1990; 336: 1044–46.PubMedCrossRefGoogle Scholar
  2. 2.
    Betley MJ, Borst DW, Regassa LB. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: A comparative study of their molecular biology. Chem Immunol 1992; 55: 1–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Ren K, Bannan JD, Pancholi V et al. Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med 1994; 180: 1675–83.PubMedCrossRefGoogle Scholar
  4. 4.
    Bergdoll MS. Enterotoxins. In: Easmon CSF, Adlam C, eds. Staphylococci and Staphylococcal Infections. London: Academic Press, 1983: 187–248.Google Scholar
  5. 5.
    Bohach GA, Fast DJ, Nelson RD et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17: 251–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Schlievert PM. Role of toxic shock syndrome toxin 1 in toxic shock syndrome: Overview. Rev Infect Dis 1989; 11: S107–09.PubMedCrossRefGoogle Scholar
  7. 7.
    Cone LA, Woodard DR, Byrd RG et al. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992; 165: 638–43.PubMedCrossRefGoogle Scholar
  8. 8.
    Newbould MJ, Malam J, Mclllmurray JM et al. Immunohistological localisation of staphylococcal toxic shock syndrome (TSST-1) antigen in sudden infant death syndrome. J Clin Pathol 1989; 42: 935–39.PubMedCrossRefGoogle Scholar
  9. 9.
    Leung DYM, Meissner HC, Fulton DR et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342: 1385–88.PubMedCrossRefGoogle Scholar
  10. 10.
    Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Curr Prob Pediatr 1991; 21: 387–405.Google Scholar
  11. 11.
    Marrack P, Kappler JW. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Brown JH, Jardetsky TS, Gorga JC et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33–39.PubMedCrossRefGoogle Scholar
  13. 13.
    Dellabona P, Peccoud J, Kappler J et al. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990; 62: 1115–21.PubMedCrossRefGoogle Scholar
  14. 14.
    Karp DR, Teletski CL, Scholl P et al. The al domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 1990; 346: 474–76.PubMedCrossRefGoogle Scholar
  15. 15.
    White J, Herman A, Pullen AM et al. The Vb-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27–35.PubMedCrossRefGoogle Scholar
  16. 16.
    Herman A, Kappler JW, Marrack P et al. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Ann Rev Immunol 1991; 9: 745–72.CrossRefGoogle Scholar
  17. 17.
    Jardetsky TS, Brown JH, Gorga JC et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994; 368: 711–18.CrossRefGoogle Scholar
  18. 18.
    Bergdoll MS, Crass BA, Reiser RF et al. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcal aureus isolates. Lancet 1981; 2: 1017–21.CrossRefGoogle Scholar
  19. 19.
    Schlievert PM, Shands KN, Dan BB et al. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 1981; 96: 14–18.Google Scholar
  20. 20.
    Passalacqua EF, Brehm RD, Acharya KR et al. Purification, crystallization and preliminary x-ray analysis of toxic shock syndrome toxin-1 from Staphylococcus aureus. J Mol Biol 1992; 228: 983–86.PubMedCrossRefGoogle Scholar
  21. 21.
    Earhart CA, Prasad GS, Murray DL et al. Growth and analysis of crystal forms of toxic shock syndrome toxin 1. Proteins 1993; 17: 329–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee PK, Kreiswirth BN, Deringer JR et al. Nucleotide sequences and biological properties of toxic shock syndrome toxin-1 from ovine and bovine-associated Staphylococcus aureus. J Infect Dis 1992; 1056–63.Google Scholar
  23. 23.
    Prasad GS, Earhart CA, Murray D et al. Structure of toxic shock syndrome toxin-1. Biochemistry 1993; 32: 13761–66.PubMedCrossRefGoogle Scholar
  24. 24.
    Acharya KR, Passalacqua EF, Jones EY et al. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 1994; 367: 94–97.PubMedCrossRefGoogle Scholar
  25. 26.
    Overington JP. Comparison of three-dimensional structures of homologous proteins. Curr Opin Struct Biol 1992; 2: 394–401.CrossRefGoogle Scholar
  26. 27.
    Kraulis PJ. Similarity of protein G and ubiquitin. Science 1991; 254: 581–82.PubMedCrossRefGoogle Scholar
  27. 28.
    Murzin AG. OB(oligonucleotide/oligosaccharide binding)-fold: Common structural and functional solution for nonhomologous sequences. EMBO J 1993; 12: 861–67.PubMedGoogle Scholar
  28. 29.
    Hynes T, Fox RO. The crystal structure of staphylococcal nuclease refined at 1.7 A resolution. Proteins 1991; 10: 92–105.PubMedCrossRefGoogle Scholar
  29. 30.
    Hol WJ, et al. Chapter 8 in this book. 1996.Google Scholar
  30. 31.
    Schindelin H, Marahiel MA, Heinemann U. Universal nucleic acid-binding domain revealed by the crystal structure of the B. subtilis major cold-shock protein. Nature 1993; 364: 164–68.PubMedCrossRefGoogle Scholar
  31. 32.
    Williamson RA, Martorell G, Carr MD et al. Solution structure of the active domain of tissue inhibitor of metalloproteinase-2. A new member of the OB fold protein family. Biochemistry 1994; 33: 11745–59.PubMedCrossRefGoogle Scholar
  32. 33.
    Dao-pin S, Anderson DE, Baase WA et al. Structural and thermodynamic consequences of burying a charged residue within the hydrophobic core of T4 lysozyme. Biochemistry 1991; 30: 11521–29.Google Scholar
  33. 34.
    Edwin C, Kass EH. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments. Infect Immun 1989; 57: 2230–36.PubMedGoogle Scholar
  34. 35.
    Swaminathan S, Furey W, Pletcher J et al. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 1992; 359: 801–06.PubMedCrossRefGoogle Scholar
  35. 36.
    Swaminathan S et al. Chapter 12 in this book. 1995.Google Scholar
  36. 37.
    Fraser JD, Urban RG, Strominger J et al. Zinc regulates the function of two superantigens. Proc Natl Acad Sci USA 1992; 89: 5507–11.PubMedCrossRefGoogle Scholar
  37. 38.
    Hurley JM, Shimonkevitz R, Hanagan A et al. Identification of class II MHC and T cell receptor binding sites in the superantigen toxic shock syndrome toxin-1. J Exp Med 1995; 181: 2229–35.PubMedCrossRefGoogle Scholar
  38. 39.
    Kim JS, Urban RG, Strominger JL et al. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994; 266: 1870–74.PubMedCrossRefGoogle Scholar
  39. 40.
    Labrecque N, Thibodeau J, Mourad W et al. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J Exp Med 1994; 180: 1921–29.PubMedCrossRefGoogle Scholar
  40. 41.
    Deckhut AM, Chien Y-H, Blackman MA et al. Evidence for a functional interaction between the b chain of major histocompatibility complex class II and the T cell receptor a chain during recognition of a bacterial superantigen. J Exp Med 1994; 180: 1931–35.PubMedCrossRefGoogle Scholar
  41. 42.
    Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 1994; 2: 245–51.PubMedCrossRefGoogle Scholar
  42. 43.
    Blanco L, Choi EM, Connolly K et al. Mutants of staphylococcal toxic shock syndrome toxin 1: Mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun 1990; 58: 3020–28.PubMedGoogle Scholar
  43. 44.
    Irwin MJ, Hudson KR, Fraser JD et al. Enterotoxin residues determining T cell receptor Vb binding specificity. Nature 1992; 359: 841–43.PubMedCrossRefGoogle Scholar
  44. 45.
    Bonventre PF, Heeg H, Cullen C et al. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun 1993; 61: 793–99.PubMedGoogle Scholar
  45. 47.
    Derrick JP, Wigley DB. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature 1992; 359: 752–54.PubMedCrossRefGoogle Scholar
  46. 48.
    Harris TO, Grossman D, Kappler JW et al. Lack of complete correlation between emetic and T cell stimulatory activities of staphylococcal enterotoxins. Infect Immun 1993; 61: 3175–83.PubMedGoogle Scholar
  47. 49.
    Hovde CJ, Marr JC, Hoffmann ML et al. Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin Cl. Molec Microbiol 1994; 13: 897–909.CrossRefGoogle Scholar
  48. 50.
    Murray DL, Prasad GS, Earhart CA et al. Immunological and biochemical properties of mutants of toxic shock syndrome toxin-1. J Immunol 1994; 152: 87–95.PubMedGoogle Scholar
  49. 51.
    Murray DL, Earhart CA, Mitchell DT et al. Localization of biologically important regions on toxic shock syndrome toxin-1. Infect Immun 1995; in press.Google Scholar
  50. 52.
    Lee PK, Vercellotti GM, Deringer JR et al. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J Infect Dis 1991; 164: 711–19.PubMedCrossRefGoogle Scholar
  51. 53.
    Kushnaryov VM, MacDonald HS, Reiser RF et al. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect Dis 1989; 11: S282–87.PubMedCrossRefGoogle Scholar
  52. 54.
    Kraulis PJ. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Cryst 1991; 24: 946–50.CrossRefGoogle Scholar
  53. 55.
    Nichols A, Bharadwaj R, Honig B. GRASP: Graphical representation and analysis of surface properties. Biophys J 1993; 64: A166.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Douglas H. Ohlendorf
  • David T. Mitchell
  • G. Sridhar Prasad
  • R. Radhakrishnan
  • Cathleen A. Earhart
  • Patrick M. Schlievert

There are no affiliations available

Personalised recommendations